FWM
EW icon

FSA Wealth Management’s Edwards Lifesciences EW Stock Holding History

FSA Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$35.4K Hold
455
– – 0.01% 188
2025
Q2 		$35.6K Hold
455
– – 0.01% 178
2025
Q1 		$33K Hold
455
– – 0.01% 179
2024
Q4 		$33.7K Hold
455
– – 0.01% 185
2024
Q3 		$30K Buy
+455
New +$33.1K 0.01% 200
2024
Q1 		$43.5K Hold
455
– – 0.02% 162
2023
Q4 		$35K Buy
+455
New +$31.7K 0.02% 174

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

FSA Wealth Management's EW Position: Q3 2025 in Review

FSA Wealth Management held its Edwards Lifesciences (EW) position steady in Q3 2025 at 455 shares worth $35.4K. The position accounts for 0.01% of the portfolio, ranked #188.

FSA Wealth Management first reported a position in EW in Q4 2023 and has held it in 7 quarters since. The position peaked at $43.5K in Q1 2024. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • FSA Wealth Management held 455 shares of Edwards Lifesciences worth $35.4K as of Q3 2025.
  • FSA Wealth Management left its Edwards Lifesciences share count unchanged in Q3 2025.
  • Edwards Lifesciences made up 0.01% of FSA Wealth Management's portfolio in Q3 2025, its #188 holding.
  • FSA Wealth Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 7 quarters since.
  • FSA Wealth Management's Edwards Lifesciences position peaked at $43.5K in Q1 2024.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.